← Back to OLMA

Olema Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 10/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 10/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 13/05/2025
−$63−$53−$42−$44−$30−$35−$30−$31
−$0.61−$0.52−$0.49−$0.51−$0.36−$0.60−$0.54−$0.56
104103868585575656

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.